Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common stock, $0.001 par value
-
Shares outstanding
-
63.2M
-
Number of holders
-
122
-
Total 13F shares, excl. options
-
38.4M
-
Shares change
-
+492K
-
Total reported value, excl. options
-
$226M
-
Value change
-
+$595K
-
Number of buys
-
65
-
Number of sells
-
-69
-
Price
-
$5.88
Significant Holders of TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI) as of Q2 2025
155 filings reported holding TMCI - TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value as of Q2 2025.
TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI) has 122 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 38.4M shares
of 63.2M outstanding shares and own 60.76% of the company stock.
Largest 10 shareholders include ARMISTICE CAPITAL, LLC (6.26M shares), BlackRock, Inc. (3.77M shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (3.1M shares), VANGUARD GROUP INC (2.73M shares), GAGNON SECURITIES LLC (2.25M shares), JPMORGAN CHASE & CO (1.78M shares), CIBC Private Wealth Group LLC (1.69M shares), MILLENNIUM MANAGEMENT LLC (1.52M shares), GEODE CAPITAL MANAGEMENT, LLC (1.12M shares), and MORGAN STANLEY (1.02M shares).
This table shows the top 122 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.